Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - A mechanism of immune evasion?

Nature Medicine

Volumn 2, Issue 12, 1996, Pages 1361-1366

  Strand, Susanne ^a   Hofmann, Walter J ^b   Hug, Hubert ^c   Müller, Martina ^a   Otto, Gerd ^a   Strand, Dennis ^d   Mariani, Sara M ^d   Stremmel, Wolfgang ^a   Krammer, Peter H ^d   Galle, Peter R ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b Institute of Pathology   (Germany)

^c Center for Molecular Biology   (Germany)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN;

APOPTOSIS; ARTICLE; CANCER CELL DESTRUCTION; CARCINOGENESIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIGAND BINDING; LIVER CARCINOMA; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS, CD95; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; BLEOMYCIN; CARCINOMA, HEPATOCELLULAR; COCULTURE TECHNIQUES; DNA FRAGMENTATION; DOWN-REGULATION; FAS LIGAND PROTEIN; HUMANS; JURKAT CELLS; LIGANDS; LIVER NEOPLASMS; MEMBRANE GLYCOPROTEINS; RNA, MESSENGER; RNA, NEOPLASM; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 16144363507     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1296-1361     Document Type: Article

References (30)

1. Krammer, P.H., Behrmann, I., Daniel, P., Dhein, D. & Debatin, K.-M. Regulation of apoptosis in the immune system. Curr. Opin. Immunol. 6, 279-289 (1994).
2. Apasov, S., Redegeld, F. & Sitkovsky, M. Cell-mediated cytotoxicity: Contact and secreted factors. Curr. Opin. Immunol. 5, 404-410 (1993).
3. Lowin, B., Hahne, M., Mattmann, C. & Tschopp, J. Cytolytic T-cell cytotoxicity is mediated through perform and Fas lytic pathways. Nature 370, 650-652 (1994).
4. Kägi, D. et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369, 31-37 (1994).
5. Kägi, D. et al. Fas and perforin pathways as major mechanisms of T-cell-mediated cytotoxicity. Science 265, 528-530 (1994).
6. 2+-independent T cell-mediated cytotoxicity. J. Exp. Med. 177, 195-200 (1993).
7. Gilette-Ferguson, I. & Sidman, C.L. A specific intercellular pathway of apoptotic cell death is defective in the mature peripheral T cells of autoimmune lpr and gld mice. Eur. J. Immunol. 24, 1181-1185(1994).
8. Hanabuchi, S. et al. Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity. Proc. Natl. Acad. Sci. USA 91, 4930-4934 (1994).
9. + cytotoxic T cells. Proc. Natl. Acad. Sci. USA 91, 4185-4189 (1994).
10. + T-cell mediated cytotoxicity. Immunology 152, 1127-1133 (1994).
11. Vignaux, F. & Golstein, P. Fas-based lymphocyte-mediated cytotoxicity against syngeneic activated lymphocytes: A regulatory pathway? Eur. J. Immunol. 24, 923-927 (1994).
12. Leithäuser, F. et al. Constitutive and induced expression of APO-1, a new member of the NGF/TNF receptor superfamily, in normal and neoplastic cells. Lab. Invest. 69, 415-429 (1993).
13. Galle, P.R. et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J. Exp. Med. 182, 1223-1230 (1995).
14. Ogasawara, J. et al. Lethal effects of the anti-Fas antibody in mice. Nature 364, 806-809 (1993).
15. Bellgrau, D. et al. A role for CD95 ligand in preventing graft rejection. Nature 377, 630-6322 (1995).
16. Griffith, T.S., Brunner, T., Fletcher, S.M., Green, D.R. & Ferguson, T.A. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 17, 1189-1192 (1995).
17. Badley, A.D. rt al. Upregulation of Fas ligand expression by human immunodeficient virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J. Virol. 70, 199-206 (1996).
18. Volkmann, M. et al. P53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation. Oncogene 9, 195-204 (1994).
19. Peter, M.E. rt al. APO-1 (CD95)-dependent and -independent antigen receptor-induced apoptosis in human T and B cell lines. Int. Immunol. 7, 1873-1877 (1995).
20. Friesen, C., Herr, I., Krammer, P.H. & Debatin, K.-M. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nature Med. 2, 574-577 (1996).
21. Trauth, B.C. et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245, 301-305 (1989).
22. Nicoletti, I., Migliorati, G., Paggliacci, M.C., Grignani, F. & Riccardi, C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139, 271-279 (1991).
23. Dhein, J. et al. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. J. Immunol. 149, 3166-3173 (1992).
24. Tanaka, M. et al. Fas ligand in human serum. Nature Med. 2, 317-322 (1996).
25. Yagita, H., Seino, K.-I., Kayagaki, N. & Okumura, K. CD95 ligand in graft rejection [letter]. Nature 379, 682 (1996).
26. Angerer, L.M. & Angerer, R.C. In situ hybridization to cellular RNA with radiolabeled RNA probes. in In Situ hybridization: A Practical Approach (ed. Wilkinson, D.G.) 15-32 (Oxford Univ. Press, New York, 1992).
27. Aden, D.P., Fogel, A., Plotkin, S., Damjanov, I. & Knowles, B.B. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature 282, 615-616 (1979).
28. Sellins, K.S. & Cohen, J.J. Gene induction by γ-irradiation leads to DNA fragmentation in lymphocytes. Immunol. 139, 3199-3206 (1987).
29. Southern, E.M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98, 503-517 (1975).
30. Mariani, S.M., Matiba, B., Bäumler, C. & Krammer, P. Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases. Eur. J. Immunol. 25, 2303-2307 (1995).